Skip to content
August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape strategic-expansion-profusa-targets-g3-vision-labs-in-ambitious-bid-to-dominate-diagnostics-landscape
  • Treatment Innovations

Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape

Siti Muinah August 3, 2026
In a move that signals a significant pivot toward integrated healthcare solutions, California-based digital health innovator Profusa...
Read More Read more about Strategic Expansion: Profusa Targets G3 Vision Labs in Ambitious Bid to Dominate Diagnostics Landscape
Strengthening Global Health Security: France and WHO Solidify Strategic Partnership with €24 Million Commitment strengthening-global-health-security-france-and-who-solidify-strategic-partnership-with-e24-million-commitment
  • Breast Cancer Prevention and Lifestyle

Strengthening Global Health Security: France and WHO Solidify Strategic Partnership with €24 Million Commitment

Neng Nana August 3, 2026
GENEVA, 17 October 2024 — In a move underscoring the enduring synergy between European diplomacy and international...
Read More Read more about Strengthening Global Health Security: France and WHO Solidify Strategic Partnership with €24 Million Commitment
The New Era of Precision Oncology: Key Breakthroughs from ASCO 2026 the-new-era-of-precision-oncology-key-breakthroughs-from-asco-2026
  • Patient Advocacy and Support

The New Era of Precision Oncology: Key Breakthroughs from ASCO 2026

Sagoh August 3, 2026
The 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, represented a watershed moment...
Read More Read more about The New Era of Precision Oncology: Key Breakthroughs from ASCO 2026
Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round global-health-at-a-crossroads-g20-nations-rally-behind-whos-landmark-investment-round
  • Global Breast Cancer Awareness

Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round

Asep Darmawan August 3, 2026
RIO DE JANEIRO – In a significant display of geopolitical alignment, health ministers from the G20 nations...
Read More Read more about Global Health at a Crossroads: G20 Nations Rally Behind WHO’s Landmark Investment Round
Navigating the Unthinkable: A Guide to Supporting Children When a Loved One Faces Terminal Illness navigating-the-unthinkable-a-guide-to-supporting-children-when-a-loved-one-faces-terminal-illness
  • Survivorship and Post-Treatment

Navigating the Unthinkable: A Guide to Supporting Children When a Loved One Faces Terminal Illness

Ammar Sabilarrohman August 3, 2026
By Kelsey Mora, CCLS, LCPC Chief Clinical Officer at Pickles Group When families receive the news that...
Read More Read more about Navigating the Unthinkable: A Guide to Supporting Children When a Loved One Faces Terminal Illness
Precision Medicine in Neurology: New Genomic Testing to Revolutionize Stroke Prevention precision-medicine-in-neurology-new-genomic-testing-to-revolutionize-stroke-prevention
  • Genomics and Precision Medicine

Precision Medicine in Neurology: New Genomic Testing to Revolutionize Stroke Prevention

Siti Muinah August 3, 2026
In a landmark shift toward personalized medicine, the National Institute for Health and Care Excellence (NICE) has...
Read More Read more about Precision Medicine in Neurology: New Genomic Testing to Revolutionize Stroke Prevention
Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile diakonos-oncology-initiates-landmark-phase-i-ii-trial-for-refractory-melanoma-with-promising-early-safety-profile
  • Medical Research and Clinical Trials

Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile

Evan Lee Salim August 3, 2026
California, USA & Alabama, USA – August 3, 2026 – Diakonos Oncology has marked a significant milestone...
Read More Read more about Diakonos Oncology Initiates Landmark Phase I/II Trial for Refractory Melanoma with Promising Early Safety Profile
The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War the-battle-for-the-340b-program-a-multi-billion-dollar-tug-of-war
  • Treatment Innovations

The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War

Asro August 3, 2026
The federal 340B Drug Pricing Program, once a niche mechanism designed to help safety-net providers stretch thin...
Read More Read more about The Battle for the 340B Program: A Multi-Billion Dollar Tug-of-War
Bridging the Gap: Addressing Critical Barriers to Cancer Risk Assessment in Gender-Affirming Care bridging-the-gap-addressing-critical-barriers-to-cancer-risk-assessment-in-gender-affirming-care
  • Clinical Oncology Education

Bridging the Gap: Addressing Critical Barriers to Cancer Risk Assessment in Gender-Affirming Care

Sagoh August 3, 2026
Introduction: A Disparity in Preventative Medicine For transgender and gender-diverse (TGD) individuals, the journey toward gender-affirming surgery...
Read More Read more about Bridging the Gap: Addressing Critical Barriers to Cancer Risk Assessment in Gender-Affirming Care
The Fractured Landscape: How State Policies Are Redefining Abortion Coverage in America the-fractured-landscape-how-state-policies-are-redefining-abortion-coverage-in-america
  • Breast Cancer Legislation and Policy

The Fractured Landscape: How State Policies Are Redefining Abortion Coverage in America

Azzam Bilal Chamdy August 3, 2026
Editorial Note: This report was updated on July 24, 2026, to incorporate the latest legislative shifts within...
Read More Read more about The Fractured Landscape: How State Policies Are Redefining Abortion Coverage in America

Posts pagination

Previous 1 … 20 21 22 23 24 25 26 … 417 Next

Recent Posts

  • The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates
  • The Cosmic Pivot: Navigating the Solar Eclipse and the Shift of Mercury and Mars (August 9–15, 2026)
  • A New Frontier in Cancer Immunotherapy: King’s College London Unveils Groundbreaking IgE Antibody Treatment
  • Zimmer Biomet Surges: Q2 Financials Spark Market Confidence and Upgraded 2026 Outlook
  • From a Single Stand to a National Movement: Celebrating a Decade of the Pink Lemonade Stand Challenge

Recent Comments

No comments to show.

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

the-dismantling-of-u-s-global-health-assessing-the-impact-of-the-new-executive-mandates
  • Breast Cancer Legislation and Policy

The Dismantling of U.S. Global Health: Assessing the Impact of the New Executive Mandates

Azzam Bilal Chamdy August 8, 2026
the-cosmic-pivot-navigating-the-solar-eclipse-and-the-shift-of-mercury-and-mars-august-9-15-2026
  • Integrative Oncology and Holistic Care

The Cosmic Pivot: Navigating the Solar Eclipse and the Shift of Mercury and Mars (August 9–15, 2026)

Neng Nana August 8, 2026
a-new-frontier-in-cancer-immunotherapy-kings-college-london-unveils-groundbreaking-ige-antibody-treatment
  • Medical Research and Clinical Trials

A New Frontier in Cancer Immunotherapy: King’s College London Unveils Groundbreaking IgE Antibody Treatment

Reynand Wu August 8, 2026
zimmer-biomet-surges-q2-financials-spark-market-confidence-and-upgraded-2026-outlook
  • Treatment Innovations

Zimmer Biomet Surges: Q2 Financials Spark Market Confidence and Upgraded 2026 Outlook

Reynand Wu August 8, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.